MAP3K5 and ovarian carcinoma: To further confirm the role of ASK1, knockdown of ASK1 expression using siRNA reduced the loss of mitochondrion membrane potential and apoptotic ratio in ovarian cancer cells treated with the combination of low glucose and metformin, which suggests that low glucose and metformin-induced mitochondrial damage are the consequence of ASK1/Noxa pathway activation.